Skip to content

Ardea Biosciences, Inc./DE

Delisted

CIK 1103390fmd_0F6C2VNG9QS1YKY9BJ756VBW2YManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2009 to Mar 31, 2012, 9 periods

Latest annual · FY2011

Millions
Total revenues
7
Operating income
(87)
Net income
(87)
Free cash flow
(61)

Latest quarter · Q1 FY2012

Millions
Total revenues
1
Operating income
(41)
Net income
(41)
Free cash flow
(41)
Open Financials

Ardea Biosciences, Inc./DE financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2011FY2010ChangeSource
Revenue$7.3 million$27.4 million-73.4%10-K 2012-03-09 · proof
Operating income-$86.7 million-$41.1 million10-K 2012-03-09 · proof
Net income-$86.6 million-$41.6 million10-K 2012-03-09 · proof
Cash from operating activities-$60 million-$49.1 million10-K 2012-03-09 · proof
Free cash flow-$61.4 million-$49.6 million10-K 2012-03-09 · proof
Total assets$104.2 million$100.5 million+3.8%10-K 2012-03-09 · proof
Total liabilities$22 million$23.3 million-5.8%10-K 2012-03-09 · proof
Cash and cash equivalents$4.4 million$15.9 million-72.1%10-K 2012-03-09 · proof
Total debt$303,000$3.6 million-91.5%10-Q 2012-05-07 · proof
What was Ardea Biosciences, Inc./DE's revenue in fiscal 2011?
Ardea Biosciences, Inc./DE reported revenue of $7.3 million for fiscal 2011 (the year ended Dec 31, 2011), against $27.4 million the year before (-73.4%). Source: the 10-K filed with the SEC on Mar 9, 2012. SEC
What was Ardea Biosciences, Inc./DE's operating income in fiscal 2011?
Ardea Biosciences, Inc./DE reported operating income of -$86.7 million for fiscal 2011 (the year ended Dec 31, 2011), against -$41.1 million the year before. Source: the 10-K filed with the SEC on Mar 9, 2012. SEC
What was Ardea Biosciences, Inc./DE's net income in fiscal 2011?
Ardea Biosciences, Inc./DE reported net income of -$86.6 million for fiscal 2011 (the year ended Dec 31, 2011), against -$41.6 million the year before. Source: the 10-K filed with the SEC on Mar 9, 2012. SEC
What was Ardea Biosciences, Inc./DE's cash from operating activities in fiscal 2011?
Ardea Biosciences, Inc./DE reported cash from operating activities of -$60 million for fiscal 2011 (the year ended Dec 31, 2011), against -$49.1 million the year before. Source: the 10-K filed with the SEC on Mar 9, 2012. SEC
What was Ardea Biosciences, Inc./DE's free cash flow in fiscal 2011?
Ardea Biosciences, Inc./DE reported free cash flow of -$61.4 million for fiscal 2011 (the year ended Dec 31, 2011), against -$49.6 million the year before. Source: the 10-K filed with the SEC on Mar 9, 2012. SEC
What are Ardea Biosciences, Inc./DE's total assets?
As of Dec 31, 2011, Ardea Biosciences, Inc./DE reported total assets of $104.2 million, against $100.5 million a year earlier (+3.8%). Source: the 10-K filed with the SEC on Mar 9, 2012. SEC
What are Ardea Biosciences, Inc./DE's total liabilities?
As of Dec 31, 2011, Ardea Biosciences, Inc./DE reported total liabilities of $22 million, against $23.3 million a year earlier (-5.8%). Source: the 10-K filed with the SEC on Mar 9, 2012. SEC
What are Ardea Biosciences, Inc./DE's cash and cash equivalents?
As of Dec 31, 2011, Ardea Biosciences, Inc./DE reported cash and cash equivalents of $4.4 million, against $15.9 million a year earlier (-72.1%). Source: the 10-K filed with the SEC on Mar 9, 2012. SEC
What is Ardea Biosciences, Inc./DE's total debt?
As of Dec 31, 2011, Ardea Biosciences, Inc./DE reported total debt of $303,000, against $3.6 million a year earlier (-91.5%). Source: the 10-Q filed with the SEC on May 7, 2012. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1103390&period_type=annual&limit=5"

Information only, not investment advice.